Replies to post #582536 on NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

Crossover was unavoidable. LP is smart - she converted that part to an rGBM trial. Two trials within a trial. Who else could do all these things except the smart LP. The contemporary idiotic trialists are jealous.

[The Danish Dude]

Don’t miss the NYAS event this year! It looks like PD1 combo will be a central topic.

Precisely!

1) So, NWBO hires the man who has been at NYAS for 30 years.
2) He becomes the chairman of said Session 11 regarding resistance.
3) Session 11 moves to Session 1.
4) Speaker to be announced
5) Linda Liau have made the 4 presentations below regarding resistance, ALL revolving around DCVax in combo with PD1.
6) All presentations had SPORE as sub heading. Nudge nudge. SPORE = combo trials
7) Al Musellas interview with LL got censored regarding the PD1 combo results. Why?
8) Because those results were already to be used in a big PR event, at NYAS, seemingly already getting prepared for by the hiring of George Zavoico?
9) And first time combo trial and interim results with Merck and Keytruda will PUBLICALLY get announced at a big event.
10) WHAMMY!

PS: Thanks for all your greetings yesterday. I appreciate that very much.